RRDi Education Grants
Rosaceans can make a difference in rosacea research by joining the RRDi as a corporate member. Please join. The RRDi is planning on doing some novel rosacea research. You can become involved with this volunteer movement of rosaceans making a difference in the direction of the research. Never underestimate the power of rosaceans volunteering. For example, you could volunteer as a grant writer (if you have no experience you could learn how). If you are a professional grant writer, or would like to learn how to write grants for rosacea research, please click here.
Joel T. Bamford, M.D., wrote an article in the Journal of the RRDi entitled, "Is it possible for rosaceans to do research?" The answer to that question is joining our cause and making this possible. The RRDi is in the forefront of the medical digital revolution which you can be a part of. For more information click here.
"However, as another important outcome, their analyses also highlighted the need for better-quality studies evaluating treatments for rosacea....The reviewers also found there were no randomized, controlled trials evaluating other treatments commonly used for rosacea, including doxycycline, minocycline, isotretinoin, laser therapy, erythromycin, dapsone and topical tretinoin." 
According to Michael Detmar, M.D., in 2003, only one paper was published for every 144,000 rosacea patients in the United States, compared to a 1-to-11 ratio for melanoma and 1 to 4,900 for psoriasis. [Source]
If you want to become involved as a volunteer you can begin to educate yourself with these two subjects on rosacea research:
Rosacea Research in Perspective of Idiopathic Diseases
Rosaceans Funding Rosacea Research
Could 10K members of the RRDi get together and each donated one dollar and fund a double blind, placebo controlled, peer reviewed clinical study research paper on rosacea? Only if you become involved. That is what volunteering is all about. Donate.
 Rosacea Treatment Studies Scrutinized by Reviewers
Better-quality assessments essential to evaluate treatments, analysis shows
Dermatology Times, Publish date: Feb 1, 2005 By: Cheryl Guttman